These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8692060)

  • 1. Screening--sensitivity, specificity and hepatitis C.
    Stevenson EM; Thompson SC; Crofts N
    Med J Aust; 1996 Jul; 165(2):120. PubMed ID: 8692060
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening--sensitivity, specificity and hepatitis C.
    Davis R
    Med J Aust; 1996 Feb; 164(3):187-8. PubMed ID: 8628143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Present status of infectious diseases transmitted by blood transfusion and the preventive measures].
    Shimoyama T
    Masui; 1999; 48 Suppl():S33-40. PubMed ID: 10785958
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 5. The risk of transfusion-transmitted infections in sub-Saharan Africa.
    Jayaraman S; Chalabi Z; Perel P; Guerriero C; Roberts I
    Transfusion; 2010 Feb; 50(2):433-42. PubMed ID: 19843290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT.
    Seed CR; Cheng A; Ismay SL; Bolton WV; Kiely P; Cobain TJ; Keller AJ;
    Transfusion; 2002 Oct; 42(10):1365-72. PubMed ID: 12423522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comments on the position of Sibrowski et al. on the comment by v. Bormann et al.: autologous blood is safer than donated blood--fact or fiction?].
    Lorentz A; Tolksdorf B; Becker P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Mar; 31(2):120. PubMed ID: 8652764
    [No Abstract]   [Full Text] [Related]  

  • 8. Contaminated blood.
    Machin SJ
    Med Leg J; 2004; 72(Pt 3):77-87. PubMed ID: 15524115
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C and human immunodeficiency virus infection following ozone autohaemotherapy.
    Daschner FD
    Eur J Clin Microbiol Infect Dis; 1997 Aug; 16(8):620. PubMed ID: 9323479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Demonstrating antibodies against hepatitis C virus in transfusion practice. Viral Hepatitis Working Group of the Société Française de la Transfusion Sanguine].
    Maisonneuve P; Noël L
    Transfus Clin Biol; 1994; 1(5):397-400. PubMed ID: 7529098
    [No Abstract]   [Full Text] [Related]  

  • 11. [Detection of the nucleic acids of hepatitis B and C viruses and human immunodeficiency virus for the biological screening of blood donations. Viral Hepatitis and Retrovirus Working Groups and Subgroup for Molecular Biology Applied to Transfusion Virology of the French Blood Transfusion Society].
    Laperche S
    Transfus Clin Biol; 1998 Apr; 5(2):139-46. PubMed ID: 9618839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-awaited Canadian blood report released.
    Murray T
    Nat Med; 1998 Jan; 4(1):10. PubMed ID: 9427591
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood-bank testing for infectious diseases: how safe is blood transfusion?
    Strong DM; Katz L
    Trends Mol Med; 2002 Jul; 8(7):355-8. PubMed ID: 12114117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous blood transfusion: the risks and alternatives.
    Williamson L
    Br J Haematol; 1994 Nov; 88(3):451-8. PubMed ID: 7819059
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-cost screening of blood for HCV infection in the developing world.
    Mujeeb SA; Hafiz A
    Vox Sang; 1998; 74(3):210. PubMed ID: 9595654
    [No Abstract]   [Full Text] [Related]  

  • 17. [Introcution of Australia Management of Prevention and Treatment for Occupational Exposure to Hepatitis and HIV (Hematogenous)].
    Wang HQ; Zhang M; Li T
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Oct; 24(10):637-8. PubMed ID: 17096960
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transfusion-induced virus infections: how great is the risk?].
    Sibrowski W; Penner M; Kühnl P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():4-9. PubMed ID: 8374287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Donors blood screening and prevention of posttransfusion type C hepatitis in Japan].
    Yoshizawa H
    Uirusu; 1993 Dec; 43(2):315-21. PubMed ID: 7510090
    [No Abstract]   [Full Text] [Related]  

  • 20. Supporting needle and syringe programs in Australia.
    Rouen D; Dolan K
    Aust N Z J Public Health; 2001 Apr; 25(2):187. PubMed ID: 11357919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.